Guided Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2023 | $5.5M | $1.7M | $591.0K |
| FY2024 | $6.3M | $1.4M | $388.0K |
| FY2025 | $7.3M | $1.3M | $63.0K |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2023 | $5.5M | $1.7M | $591.0K |
| FY2024 | $6.3M | $1.4M | $388.0K |
| FY2025 | $7.3M | $1.3M | $63.0K |